Drug Description in Trials / DrugBank / KEGG DRUG
Search results
Showing 1 to 10 of 15 descriptions
| No. | 薬物名（臨床試験情報から抽出） | DrugBank | KEGG DRUG | KEGG GENES | KEGG PATHWAY | 指定難病告示番号 | ||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | ABP 959 - biosimilar to eculizumab (Soliris (TN)) | 1件: Eculizumab Eculizumab (Soliris) | 1件: Eculizumab
Eculizumab
(Soliris (TN)) 💬1. ABP 959 - biosimilar to eculizumab
| 1件: C5 C5 💬1. ABP 959 - biosimilar to eculizumab
| 11件: Alcoholic liver disease Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬 11件: Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, H ... | 1件: 62 62 💬1. ABP 959 - biosimilar to eculizumab
| ||||||||||||||||||||||||||||||||
| 2 | ABP 959 - proposed biosimilar to eculizumab (Soliris (TN)) | 1件: Eculizumab Eculizumab (Soliris) | 1件: Eculizumab
Eculizumab
(Soliris (TN)) 💬2. ABP 959 - proposed biosimilar to eculizumab
| 1件: C5 C5 💬2. ABP 959 - proposed biosimilar to eculizumab
| 11件: Alcoholic liver disease Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬 11件: Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, H ... | 1件: 62 62 💬2. ABP 959 - proposed biosimilar to eculizumab
| ||||||||||||||||||||||||||||||||
| 3 | ECULIZUMAB (Soliris (TN)) | 1件: Eculizumab Eculizumab (Soliris) | 1件: Eculizumab
Eculizumab
(Soliris (TN)) 💬3. ECULIZUMAB
| 1件: C5 C5 💬3. ECULIZUMAB
| 11件: Alcoholic liver disease Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬 11件: Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, H ... | 7件: 11 11, 13, 14, 61, 62, 109, 222 💬3. ECULIZUMAB
| ||||||||||||||||||||||||||||||||
| 4 | SB12 (proposed eculizumab biosimilar) (Soliris (TN)) | 1件: Eculizumab Eculizumab (Soliris) | 1件: Eculizumab
Eculizumab
(Soliris (TN)) 💬4. SB12 (proposed eculizumab biosimilar)
| 1件: C5 C5 💬4. SB12 (proposed eculizumab biosimilar)
| 11件: Alcoholic liver disease Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬 11件: Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, H ... | 1件: 62 62 💬4. SB12 (proposed eculizumab biosimilar)
| ||||||||||||||||||||||||||||||||
| 5 | SOLIRIS | 1件: Eculizumab Eculizumab (Soliris) | 1件: Eculizumab
Eculizumab
(Soliris (TN)) 💬5. SOLIRIS
| 1件: C5 C5 💬5. SOLIRIS
| 11件: Alcoholic liver disease Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬 11件: Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, H ... | 7件: 11 11, 13, 14, 61, 62, 109, 222 💬5. SOLIRIS
| ||||||||||||||||||||||||||||||||
| 6 | Soliris (eculizumab) | 1件: Eculizumab Eculizumab (Soliris) | 1件: Eculizumab
Eculizumab
(Soliris (TN)) 💬6. Soliris (eculizumab)
| 1件: C5 C5 💬6. Soliris (eculizumab)
| 11件: Alcoholic liver disease Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬 11件: Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, H ... | 1件: 62 62 💬6. Soliris (eculizumab)
| ||||||||||||||||||||||||||||||||
| 7 | Soliris (R) | 1件: Eculizumab Eculizumab (Soliris) | 1件: Eculizumab
Eculizumab
(Soliris (TN)) 💬7. Soliris (R)
| 1件: C5 C5 💬7. Soliris (R)
| 11件: Alcoholic liver disease Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬 11件: Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, H ... | 1件: 61 61 💬7. Soliris (R)
| ||||||||||||||||||||||||||||||||
| 8 | SOLIRIS - 300 MG CONCENTRATO PER SOLUZIONE PER INFUSIONE - USO ENDOVENOSO 1 FLACONCINO (VETRO) 30 ML (10 MG/ML) SOLIRIS- 300 MG CONCENTRATO PER SOLUZIONE PER INFUSIONE - USO ENDOVENOSO 1 FLACONCINO (VETRO) 30 ML ... | 1件: Eculizumab Eculizumab (Soliris) | 1件: Eculizumab
Eculizumab
(Soliris (TN)) 💬8. SOLIRIS - 300 MG CONCENTRATO PER SOLUZIONE PER INFUSIONE - USO ENDOVENOSO 1 FLACONCINO (VETRO) 30 ML (10 MG/ML)
| 1件: C5 C5 💬8. SOLIRIS - 300 MG CONCENTRATO PER SOLUZIONE PER INFUSIONE - USO ENDOVENOSO 1 FLACONCINO (VETRO) 30 ML (10 MG/ML)
| 11件: Alcoholic liver disease Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬 11件: Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, H ... | 3件: 13 13, 62, 109 💬
| ||||||||||||||||||||||||||||||||
| 9 | Soliris 300 | 1件: Eculizumab Eculizumab (Soliris) | 1件: Eculizumab
Eculizumab
(Soliris (TN)) 💬9. Soliris 300
| 1件: C5 C5 💬9. Soliris 300
| 11件: Alcoholic liver disease Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬 11件: Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, H ... | 1件: 62 62 💬9. Soliris 300
| ||||||||||||||||||||||||||||||||
| 10 | SOLIRIS 300 mg concentrado para solución para perfusión | 1件: Eculizumab Eculizumab (Soliris) | 1件: Eculizumab
Eculizumab
(Soliris (TN)) 💬10. SOLIRIS 300 mg concentrado para solución para perfusión
| 1件: C5 C5 💬10. SOLIRIS 300 mg concentrado para solución para perfusión
| 11件: Alcoholic liver disease Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬 11件: Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, H ... | 1件: 109 109 💬10. SOLIRIS 300 mg concentrado para solución para perfusión
|